1.
Public Health Rep
; 121 Suppl 1: 149-59; discussion 148, 2006.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16550776
2.
Am J Epidemiol
; 141(1): 4-9; discussion 3, 1995 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-7801964
3.
Can Med Assoc J
; 115(5): 401-3, 1976 Sep 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-953914
RESUMO
Cholera varies greatly in clinical severity; the mortality of untreated severe cholera may be as high as 60% The main clinical feature is dehydration; fluid lost in the stools may amount to 60/. Rehydration is the cornerstone of treatment. The amount of fluid required is approximately 10% of body weight in severe dehydration and 5 to 8% in moderate dehydration. Fluid therapy, which must be individualized, may be successful on its own, but chemo-therapy shortens the duration of illness. Tetracycline (in adults, 40 mg/kg for 2 days; in children, 50 mg/kg for 2 days) reduces the fluid loss and eliminates the causative organisms. Vaccination is of limited value.
Assuntos
Cólera/terapia , Adulto , Bicarbonatos/uso terapêutico , Criança , Cloranfenicol/uso terapêutico , Cólera/microbiologia , Cólera/patologia , Desidratação/terapia , Feminino , Furazolidona/uso terapêutico , Humanos , Lactatos/uso terapêutico , Gravidez , Tetraciclina/uso terapêutico , Vibrio cholerae/isolamento & purificação
4.
Am J Epidemiol
; 103(2): 141-51, 1976 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-766618